TCT-251 Abnormal glucose metabolism and adverse event rates 12 months after treatment with contemporary drug-eluting stents: Insights from the BIO-RESORT Silent Diabetes study von Kok, Marlies, von Birgelen, Clemens, Zocca, Paolo, Hartmann, Marc, Gert van Houwelingen, K., Stoel, Martin, de Man, Frits, Louwerenburg, J.Hans, Lowik, Marije, Kant, Gert, Doelman, Cees, Linssen, Gerard C.M., van der Heijden, Liefke, Doggen, Carine J.M., Tandjung, Kenneth

Volltext

TCT-549 CHANGE DAPT: clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents von von Birgelen, Clemens, Zocca, Paolo, van der Heijden, Liefke, Kok, Marlies, Stoel, Martin, Hartmann, Marc, de Man, Frits, Louwerenburg, J.Hans, Lowik, Marije, Knottnerus, Iris, Linssen, Gerard C.M., Doggen, Carine J.M., Gert van Houwelingen, K.

Volltext